We are live on ! Find out more
GIA

Gladstone Institutional Advisory Portfolio holdings

AUM $3.16B
1-Year Est. Return 29.04%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+29.04%
3 Year Est. Return
+85.59%
5 Year Est. Return
+98.47%
10 Year Est. Return
AUM
$1.29B
AUM Growth
+$267M
Cap. Flow
+$204M
Cap. Flow %
15.83%
Top 10 Hldgs %
17.26%
Holding
647
New
105
Increased
320
Reduced
156
Closed
53
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
151
Emerson Electric
EMR
$83.9B
$2.44M 0.19%
26,188
+6,217
+31% +$585K
F icon
152
Ford
F
$58.5B
$2.41M 0.19%
115,958
+83,136
+253% +$1.53M
VSDA icon
153
VictoryShares Dividend Accelerator ETF
VSDA
$246M
$2.39M 0.19%
+50,296
New +$2.3M
AUPH icon
154
Aurinia Pharmaceuticals
AUPH
$1.91B
$2.35M 0.18%
102,600
+26,100
+34% +$618K
GGG icon
155
Graco
GGG
$12.9B
$2.33M 0.18%
28,964
-598
-2% -$45.4K
CIBR icon
156
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.4B
$2.25M 0.17%
42,681
+3,291
+8% +$173K
IBM icon
157
IBM
IBM
$211B
$2.25M 0.17%
16,832
+466
+3% +$58.4K
BSV icon
158
Vanguard Short-Term Bond ETF
BSV
$44.7B
$2.22M 0.17%
27,464
+327
+1% +$26.6K
BA icon
159
Boeing
BA
$171B
$2.2M 0.17%
10,927
-527
-5% -$111K
RPV icon
160
Invesco S&P 500 Pure Value ETF
RPV
$1.65B
$2.2M 0.17%
+27,219
New +$2.17M
TMFS icon
161
Motley Fool Small-Cap Growth ETF
TMFS
$57.6M
$2.19M 0.17%
59,545
+19,231
+48% +$735K
IDXX icon
162
Idexx Laboratories
IDXX
$44.1B
$2.17M 0.17%
3,290
-831
-20% -$522K
ORCL icon
163
Oracle
ORCL
$374B
$2.15M 0.17%
24,635
-9,255
-27% -$869K
TROW icon
164
T. Rowe Price
TROW
$23.9B
$2.15M 0.17%
10,911
+3,152
+41% +$640K
ZTS icon
165
Zoetis
ZTS
$32.4B
$2.13M 0.17%
8,734
+6,801
+352% +$1.49M
FTXO icon
166
First Trust Nasdaq Bank ETF
FTXO
$305M
$2.11M 0.16%
64,314
-9,590
-13% -$325K
VCIT icon
167
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$2.11M 0.16%
22,742
+13,426
+144% +$1.26M
TEAM icon
168
Atlassian
TEAM
$25.6B
$2.09M 0.16%
5,490
+1,163
+27% +$467K
FTA icon
169
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.39B
$2.08M 0.16%
29,712
+325
+1% +$22K
TGT icon
170
Target
TGT
$65.6B
$2.06M 0.16%
8,904
-3,325
-27% -$809K
FBND icon
171
Fidelity Total Bond ETF
FBND
$26.9B
$2.05M 0.16%
38,746
-2,088
-5% -$111K
XLY icon
172
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.6B
$2.04M 0.16%
19,982
+5,006
+33% +$499K
IWR icon
173
iShares Russell Mid-Cap ETF
IWR
$56B
$2.04M 0.16%
24,590
+1,785
+8% +$147K
IBB icon
174
iShares Biotechnology ETF
IBB
$9.34B
$2.02M 0.16%
13,270
+1,988
+18% +$308K
SNPS icon
175
Synopsys
SNPS
$74.4B
$2M 0.15%
5,418
+4,524
+506% +$1.53M

Similar funds

Gladstone Institutional Advisory's Q4 2021 Portfolio in Review

As of Q4 2021, Gladstone Institutional Advisory held 647 positions worth $1.29B, up 26% from $1.02B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Gladstone Institutional Advisory deployed $204M of net new capital in Q4 2021, opening 105 new positions and adding to 320 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 Growth ETF: 262,493 shares worth $19M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Ginkgo Bioworks, an estimated $3.33M trimmed.

  • Gladstone Institutional Advisory's largest Q4 2021 buy was State Street SPDR Portfolio S&P 500 Growth ETF: 262,493 shares worth $19M.
  • Gladstone Institutional Advisory added most to Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q4 2021, an estimated $12.9M increase.
  • Gladstone Institutional Advisory's biggest Q4 2021 reduction was Ginkgo Bioworks, cutting an estimated $3.33M.
  • Gladstone Institutional Advisory fully exited First Trust Nasdaq-100 Select Equal Weight ETF in Q4 2021, selling an estimated $1.55M.
  • Gladstone Institutional Advisory's ten largest holdings make up 17% of its $1.29B portfolio in Q4 2021.
  • Gladstone Institutional Advisory opened 105 new positions and closed 53 in Q4 2021.
  • Gladstone Institutional Advisory's portfolio value rose 26% quarter-over-quarter to $1.29B.

Based on Gladstone Institutional Advisory's 13F filing for Q4 2021, filed 11 Feb 2022.